GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nirvana Life Sciences Inc (XCNQ:NIRV) » Definitions » Total Equity

Nirvana Life Sciences (XCNQ:NIRV) Total Equity : C$-0.82 Mil (As of Jan. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nirvana Life Sciences Total Equity?

Nirvana Life Sciences's total equity for the quarter that ended in Jan. 2024 was C$-0.82 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


Nirvana Life Sciences Total Equity Historical Data

The historical data trend for Nirvana Life Sciences's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nirvana Life Sciences Total Equity Chart

Nirvana Life Sciences Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Apr22 Apr23
Total Equity
Get a 7-Day Free Trial -0.74 -0.53 -0.02 -0.16 -0.94

Nirvana Life Sciences Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.55 -0.94 -0.75 -0.85 -0.82

Nirvana Life Sciences Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Nirvana Life Sciences's Total Equity for the fiscal year that ended in Apr. 2023 is calculated as

Total Equity=Total Assets(Q: Apr. 2023 )-Total Liabilities(Q: Apr. 2023 )
=0.069-1.008
=-0.94

Nirvana Life Sciences's Total Equity for the quarter that ended in Jan. 2024 is calculated as

Total Equity=Total Assets(Q: Jan. 2024 )-Total Liabilities(Q: Jan. 2024 )
=0.212-1.029
=-0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nirvana Life Sciences Total Equity Related Terms

Thank you for viewing the detailed overview of Nirvana Life Sciences's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Nirvana Life Sciences (XCNQ:NIRV) Business Description

Traded in Other Exchanges
N/A
Address
650 West Georgia Street, Suite 2110, Vancouver, BC, CAN, V6B 4N8
Nirvana Life Sciences Inc is focused on developing medical products and regimens that address addiction. The company is working on novel formulations of psilocybin and other naturally-sourced psychedelics to treat pain, opioid dependency, and other health problems.

Nirvana Life Sciences (XCNQ:NIRV) Headlines

No Headlines